Glucose, Insulin and Somatostatin Infusion for the Determination of Insulin Resistance in Liver Cirrhosis

Abstract
Twelve patients with liver cirrhosis and ten normal subjects were studied. Using a constant intravenous infusion of glucose, insulin and somatostatin over 2 1/2 hours we determined the steady state plasma glucose level (SSPG) in order to measure insulin resistance. The results demonstrated that the cirrhotic patients were insulin resistant compared to normals and that plasma glucagon does not account for the insulin resistance in these patients.